In recent years, a large number of studies have shown that direct or indirect inhibition of NLRP3 inflammasome-mediated macrophage pyroptosis reduces the release of interleukin-1β (IL-1β) and IL-18, inhibit inflammatory response, and alleviate tissue damage in ALI mice [49, 50]. This evidence concerns the gene IL18 and acute respiratory distress syndrome.